Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/23/2021
CDE Solicits Comments on the Technical Guidelines for Preparing the Ri...
7/23/2021
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
7/23/2021
Menarini AP Acquires China Rights of Cialis (Tadalafil) from Lilly
7/23/2021
NMPA Issues the List of Reference Formulations for GQCE Studies (43nd ...
7/23/2021
Recent Executive Moves
7/22/2021
AI Drug Firm Insilico Mulls IPO in the U.S.
7/22/2021
RareStone Submits Chinese NDA of Wakix (pitolisant) for Narcolepsy in ...
7/22/2021
Exscientia and GT Apeiron Therapeutics Enter Strategic Oncology R&D Pa...
7/22/2021
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
7/22/2021
Aptamer and WuXi AppTec Collaborate to Identify New Optimer Enabled Th...
7/22/2021
Merck and Adagene Ink Trial Collaboration and Supply Agreement for Com...
7/22/2021
Mabpharm/Sorrento Granted Chinese Approval for Infliximab Biobetter
7/22/2021
Ascletis Granted Chinese Approval of PIII Trial of ASC40 Combo with B...
7/22/2021
Patent Linkage in China: Up, Running And With Chinese Characteristics
7/20/2021
Review of Chinese Pharma Deals, R&D and Regulatory Developments in H1/...
7/20/2021
Synthesizing Developments on China's Patent Linkage from the July 15 B...
7/20/2021
NMPA Revises Packages Insert of Propranolol Tablets
7/20/2021
South Korea's Medipost Drops Joint Venture Plan in China
7/20/2021
Eluminex Bio Licenses FibroGen's Biosynthetic Cornea Technology and Re...
7/19/2021
CDE Issues the Writing Guidelines and Generic Format of the Production...
7/19/2021
Ascentage Enters R&D Deal with the National Cancer Institute for Clin...
7/19/2021
Frontier Reports Positive Clinical Results for First Long-acting Injec...
7/19/2021
Junshi Bio and Immorna Announce JV for mRNA-based Therapeutics and Va...
7/19/2021
Pharma DJ: ADCs and I/O Therapies Attract Massive Investments
7/16/2021
CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
7/16/2021
NHSA Issues the BMI Management Procedures for Disease Group-based Diag...
7/16/2021
Recent Executive Moves
7/16/2021
Chinese Premier Calls for More Efforts to Enhance BMI Access, Budget M...
7/15/2021
China Increases Subsidies for Basic Public Health Services
7/15/2021
China Sees Substantial Declines in Infectious Diseases
Page:
122
/
719
Total number of articles:
21549
:
[First]
[<<]
[120]
[121]
[122]
[123]
[124]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit